Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

What 300,000 Implants Say About Light Adjustable Lens

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Parkinson’s Disease Deaths Decline Among Older US Adults

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka Battles Surge in Dengue Fever, With More Than 44,000 Cases So Far This Year

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

More Than 70 Congo Medics Infected With Ebola Since Outbreak Started, WHO Says

A senior World Health Organization official said on Friday that 75 ⁠medics in the Democratic Republic of Congo had been infected with Ebola and 17 of ⁠them had died since...

US Progesterone Supplies Tighten as Menopause Treatment Demand Grows

U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone...

Moderna's MRNA Flu Vaccine Backed by FDA Advisers

Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its benefits outweigh its risks,...

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Latest News

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

A senior World Health Organization official said on Friday that 75 ⁠medics in the Democratic Republic of Congo had been infected with Ebola and 17 of ⁠them had died since...

U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone...

Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its benefits outweigh its risks,...

News All Time

Congo's Ebola Outbreak Spreads to New Health Zones

Congo's Ebola outbreak has spread ⁠to three new health zones, according to ⁠a government report published on Thursday that ⁠showed the ‌number of confirmed cases had risen...

India Raises Price Cap on Cancer Drugs to Tackle Shortage

India's drug price regulator raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge ⁠in raw material costs triggered widespread shortages,...

Good Outcomes with Ublituximab in First Real-World Study

Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Congo’s Ebola Outbreak Spreads to New Health Zone

Congo's Ebola outbreak has spread to a new health zone in the northeastern ⁠province of Ituri, authorities said on Wednesday, as fresh infections underline sustained...

Valencia Floods Highlight Missing Hospital Protocols

A cold snap that hit hundreds of thousands showed how quickly hospitals can lose order, with radiology calling for empathy, leadership, and real disaster protocols.

High-Dose Flu Shot Beats Standard Dose in Older Adults

High-dose influenza vaccine offers better protection than standard-dose influenza vaccine against several serious hospitalization outcomes in adults aged 65 years or older, a meta-analysis finds.

Why Are Ketogenic Diets Effective for Epilepsy?

A century-old dietary therapy remains one of neurology’s most effective treatments for drug-resistant epilepsy — and one of its least understood.

Berlin Hospital Discharges US Doctor Who Contracted Ebola

A U.S. citizen treated in Germany ⁠after contracting Ebola in the Democratic Republic of Congo has been discharged, ⁠a Berlin hospital said on Saturday.

Antibiotic Resistance Genes Found Across World Oceans, Italian Study Shows

Genes linked to antibiotic resistance are present across multiple ocean basins, including remote waters, according to findings ⁠released on Monday from an Italian-led...

Getting a Syphilis Test May Signal Higher Stroke Risk

Individuals who undergo syphilis testing, regardless of the result, face a substantially higher risk for stroke than individuals from the general population, a study shows.

Baricitinib May Offer Short-Term Benefits in Early Arthritis

In patients with undifferentiated arthritis, early treatment with baricitinib is linked to a greater 3-month improvement in disease activity than symptomatic treatment with NSAIDs.

Scope of Practice in Eye Care: Pendulum Swinging Too Far?

A shortage of eye specialists has led states to consider allowing nonphysicians to perform in-office surgical procedures. Medscape wants to know: What do you think of these proposed expansions of practice?

Medical Empathy: Laura Dern and Diane Ladd’s IPF Journey

The Oscar-winning actress shares what she learned as a caregiver, and what doctors can do to give patients with IPF more hope and resources.

Low Outdoor Exposure in Winter Linked to Paediatric MS Risk

Reduced outdoor exposure during winter in early childhood is linked to higher odds of developing paediatric multiple sclerosis across early-life age groups.

COPD Surfaces During Lung Cancer Screening

Leveraging lung cancer screening can improve chronic obstructive pulmonary disease detection and intervention in underserved populations.

Psilocybin May Boost Abstinence in Cocaine Use Disorder

Psilocybin added to psychotherapy is associated with a greater likelihood of abstinence in cocaine use disorder than an adjunct active placebo, a study shows.

Recommended News For You

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

Regular physical activity before cancer diagnosis may lower progression and death risks

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Pickleball program boosts health and wellness for cancer survivors, study finds

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Low PSA May Not Fully Predict Survival in Prostate Cancer

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Recommended Articles For You

Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients 

Understanding Pomalidomide: A promising drug for multiple myeloma treatment 

Essential Concepts in Oncology for Better Care 

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

2.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

3.

Mezigdomide Combinations Show Promise in Multiple Myeloma

4.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

5.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

1.

Obesity is a major risk factor for cancer

2.

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium

3.

Emerging Advances in Hematology and Quality Improvement

4.

LncRNAs in Cancer: Shaping Tumor Progression & Paving New Paths for Treatment

5.

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

3.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

4.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot